The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE”-Reference-Cited by-同舟云学术

The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE”

Published:2016-12-27 Issue:12 Volume:13 Page:e1002204
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Savas Peter^ORCID,Teo Zhi Ling^ORCID,Lefevre Christophe^ORCID,Flensburg Christoffer,Caramia Franco^ORCID,Alsop Kathryn,Mansour Mariam,Francis Prudence A.,Thorne Heather A.,Silva Maria Joao,Kanu Nnennaya,Dietzen Michelle,Rowan Andrew^ORCID,Kschischo Maik^ORCID,Fox Stephen^ORCID,Bowtell David D.,Dawson Sarah-Jane^ORCID,Speed Terence P.,Swanton Charles,Loi Sherene

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference60 articles.

1. Mutational evolution in a lobular breast tumor profiled at single nucleotide resolution;SP Shah;Nature,2009

2. Genome remodelling in a basal-like breast cancer metastasis and xenograft;L Ding;Nature,2010

3. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution;P Eirew;Nature,2014

4. Multifocal clonal evolution characterized using circulating tumor DNA in a case of metastatic breast cancer;M Murtaza;Nat Commun,2015

5. Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor;D Juric;Nature,2014

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping the transcriptional evolution of human metastatic breast cancer;Journal of Clinical Investigation;2024-09-03

2. Copy number alterations: a catastrophic orchestration of the breast cancer genome;Trends in Molecular Medicine;2024-08

3. Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer—a call for enhanced surveillance strategies;npj Precision Oncology;2024-03-29

4. Research autopsy programmes in oncology: shared experience from 14 centres across the world;The Journal of Pathology;2024-03-29

5. Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer;Cancer Research Communications;2024-02-14